SB2370

AN ACT to provide for a legislative management study regarding prescription drug transparency reporting under the federal drug discount program.

Complete·5/2/25

North Dakota SB2370 mandates health insurance coverage for insulin drugs and supplies, limiting out-of-pocket costs to $25 per thirty-day supply.

North Dakota SB2370 establishes requirements for health insurance coverage of insulin drugs and medical supplies for individuals with diabetes. The bill mandates that health benefit plans limit out-of-pocket costs for a thirty-day supply of covered insulin drugs and medical supplies to no more than $25 per pharmacy or distributor. This includes insulin drugs and supplies such as blood glucose meters, test strips, lancing devices, and syringes. The bill also specifies that it does not apply to Medicare Part D prescription drug coverage plans.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Sponsors

D
1
3
RRR
Democratic CaucusRepublican Caucus

Roll Call Votes

77 Yea

DRDRRRRRRRRRRRRRRRRRRRRRRRDRRRRDRRRRRRRRRDRRDRDRDRRDRRRRRRRRRRRRRRRRRRRRRRRRD

12 Nay

RRRRRRRRRRRR

5 Absent

RDRRR

Calendar

Apr 24, 2025

3:30 PM

Conference Committee (Senate Human Services)

Apr 23, 2025

9:00 AM

Conference Committee (Senate Human Services)

History

Jun 11, 2025

Senate

Filed with Secretary Of State 05/02

May 2, 2025

Senate

Signed by Governor 05/02

May 1, 2025

House

Signed by Speaker